FDA Inspection 1171951 — Grifols Canada Plasma II Inc.
The FDA completed an inspection of Grifols Canada Plasma II Inc. on Jun 8, 2022 in Winnipeg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 8, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Winnipeg (Canada)